| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.21 | 4e-11 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.22 | 9e-11 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.2 | 4e-08 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.19 | 6e-08 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.18 | 1e-07 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.18 | 4e-07 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.17 | 6e-07 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.16 | 3e-06 |